Hemodynamic effect of myocardial bridging.
Kersemans
Maarten
M
Heart Center, University Hospital Ghent, Ghent, Belgium.
Van Heuverswyn
Frederic
F
De Pauw
Michel
M
Gheeraert
Peter
P
Taeymans
Yves
Y
Drieghe
Benny
B
D000241:Adenosine / Q000008:administration & dosage; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000787:Angina Pectoris / Q000209:etiology / Q000503:physiopathology; D001285:Atropine; D001642:Bicycling; D017023:Coronary Angiography; D004280:Dobutamine / Q000008:administration & dosage; D015444:Exercise; D005080:Exercise Test; D006439:Hemodynamics; D006801:Humans; D006940:Hyperemia / Q000503:physiopathology; D007262:Infusions, Intravenous; D008297:Male; D008790:Metoprolol / Q000008:administration & dosage; D054084:Myocardial Bridging / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology*; D055815:Young Adult
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D004280:Dobutamine; D001285:Atropine; D008790:Metoprolol; D000241:Adenosine